Importantly, our analyses identified biallelic LoF of BRCA1 or BRCA2 in 20% and 9% of ovarian cancer samples, respectively, in line with what has been reported previously (Fig. 3B; refs. 41, 42). The gene discussed is BRCA2; the disease is ovarian cancer.